All hormone therapies including bioidentical formulations carry potential risks and benefits
The parathyroid glands, which sit on the posterior surface of each thyroid lobe, produce parathyroid hormone (PTH), which regulates calcium homeostasis
The initial dosage is typically determined based on the individuals current diabetes management regimen and their response to previous medications
The potential risk that glucagon might worsen glycemia is offset in the molecule by the powerful glucose-lowering, insulinotropic action of concurrent GLP-1 and GIP agonism
Severe renal impairment represents an important consideration
Interestingly, all other tested pathways (oxidative stress, DNA damage, and inflammatory stress) were not significantly activated by either AQ-QI or DEAQ-QI treatment (Supplementary Figure S5)